These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19628127)

  • 21. Diastolic heart function and dysfunction.
    Brutsaert DL
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V11-5. PubMed ID: 10582449
    [No Abstract]   [Full Text] [Related]  

  • 22. Heart failure with preserved ejection fraction in older adults.
    Chen MA
    Am J Med; 2009 Aug; 122(8):713-23. PubMed ID: 19635270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure.
    Zile MR; Lewinter MM
    J Am Coll Cardiol; 2007 Mar; 49(9):982-5. PubMed ID: 17336722
    [No Abstract]   [Full Text] [Related]  

  • 24. Left ventricular response to mitral regurgitation: implications for management.
    Gaasch WH; Meyer TE
    Circulation; 2008 Nov; 118(22):2298-303. PubMed ID: 19029478
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?
    van Veldhuisen DJ; McMurray JJ
    Eur J Heart Fail; 2013 Jan; 15(1):5-8. PubMed ID: 23193144
    [No Abstract]   [Full Text] [Related]  

  • 26. Appearances can deceive: even brave hearts can fail.
    Dickstein K
    Eur Heart J; 2004 Jul; 25(14):1181-2. PubMed ID: 15246633
    [No Abstract]   [Full Text] [Related]  

  • 27. Determinants of left ventricular mass in hypertensive heart disease: a complex interplay between volume, pressure, systolic function and genes.
    Perlini S
    J Hypertens; 2007 Jul; 25(7):1341-2. PubMed ID: 17563551
    [No Abstract]   [Full Text] [Related]  

  • 28. New molecular mechanism in diastolic heart failure.
    Katz AM; Zile MR
    Circulation; 2006 Apr; 113(16):1922-5. PubMed ID: 16636184
    [No Abstract]   [Full Text] [Related]  

  • 29. Heart failure in patients with left ventricular systolic dysfunction.
    Heart Failure Society Of America
    J Card Fail; 2006 Feb; 12(1):e38-57. PubMed ID: 16500571
    [No Abstract]   [Full Text] [Related]  

  • 30. Examining the concept of preserved systolic function.
    Kessler KM
    J Am Coll Cardiol; 2006 Dec; 48(12):2599-600. PubMed ID: 17174206
    [No Abstract]   [Full Text] [Related]  

  • 31. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of asymptomatic patients with reduced left ventricular ejection fraction.
    Heart Failure Society Of America
    J Card Fail; 2006 Feb; 12(1):e26-8. PubMed ID: 16500568
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of right ventricular dilation on left ventricular myocardial deformation in patients after surgical repair of tetralogy of fallot.
    Cheung EW; Liang XC; Lam WW; Cheung YF
    Am J Cardiol; 2009 Nov; 104(9):1264-70. PubMed ID: 19840574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization techniques in cardiac resynchronization therapy.
    Fischer A
    Future Cardiol; 2009 Jul; 5(4):355-65. PubMed ID: 19656060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does anticoagulation benefit patients with congestive heart failure (CHF) who have reduced left ventricular ejection fraction (LVEF) and are in normal sinus rhythm?
    Shah N; DeLeon D; Schwiebert LP; Mold JW
    J Okla State Med Assoc; 2009 Apr; 102(4):126-7. PubMed ID: 19504981
    [No Abstract]   [Full Text] [Related]  

  • 38. Letter by Tsilakis et al regarding article "subclinical left ventricular longitudinal systolic dysfunction in hypertension with no evidence of heart failure".
    Tsilakis D; Kranidis A; Karabinos E; Manolis AS
    Circ J; 2008 Jun; 72(6):1037; author reply 1038-9. PubMed ID: 18503238
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic value of left ventricular dyssynchrony in patients with heart failure.
    Bax JJ; van dWall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Aug; 44(4):937; author reply 937-8. PubMed ID: 15312886
    [No Abstract]   [Full Text] [Related]  

  • 40. [Heart failure with normal ejection fraction. A condition on its way towards better diagnosis and treatment].
    Lund LH; Persson H
    Lakartidningen; 2007 Aug 22-28; 104(34):2332. PubMed ID: 17907556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.